SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Canaccord Genuity Maintains Buy on NuVasive, Lowers Price Target to $64

Canaccord Genuity maintains NuVasive (NASDAQ:NUVA) with a Buy and lowers the price target from $68 to $64.

Benzinga · 05/07/2020 17:54

Canaccord Genuity maintains NuVasive (NASDAQ:NUVA) with a Buy and lowers the price target from $68 to $64.